Acadia Healthcare (NASDAQ:ACHC) Raised to Buy at Deutsche Bank Aktiengesellschaft

Acadia Healthcare (NASDAQ:ACHC) was upgraded by research analysts at Deutsche Bank Aktiengesellschaft from a “hold” rating to a “buy” rating in a note issued to investors on Thursday, Marketbeat reports. The firm currently has a $75.00 target price on the stock, up from their prior target price of $45.00. Deutsche Bank Aktiengesellschaft’s price objective would indicate a potential upside of 84.46% from the stock’s previous close.

Several other research analysts have also recently commented on the company. Royal Bank of Canada lowered their target price on Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a research note on Monday, November 18th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $52.00 target price on shares of Acadia Healthcare in a research report on Tuesday. KeyCorp began coverage on Acadia Healthcare in a research report on Friday, October 11th. They set a “sector weight” rating on the stock. Barclays reduced their target price on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a report on Friday, November 22nd. Finally, StockNews.com cut Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Friday, November 22nd. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $75.44.

Acadia Healthcare Trading Up 0.8 %

Shares of ACHC opened at $40.66 on Thursday. Acadia Healthcare has a 52-week low of $36.50 and a 52-week high of $87.77. The stock has a market cap of $3.78 billion, a PE ratio of 13.33, a price-to-earnings-growth ratio of 1.77 and a beta of 1.29. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The firm’s fifty day moving average is $45.39 and its two-hundred day moving average is $61.82.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The firm had revenue of $815.60 million for the quarter, compared to analyst estimates of $819.42 million. During the same quarter in the previous year, the company earned $0.91 EPS. The business’s revenue for the quarter was up 8.7% compared to the same quarter last year. Research analysts forecast that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.

Institutional Trading of Acadia Healthcare

Several large investors have recently bought and sold shares of ACHC. Blue Trust Inc. lifted its holdings in Acadia Healthcare by 86.1% in the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company’s stock worth $36,000 after buying an additional 248 shares in the last quarter. GAMMA Investing LLC raised its stake in shares of Acadia Healthcare by 57.1% in the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock valued at $42,000 after purchasing an additional 241 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new stake in Acadia Healthcare during the second quarter valued at approximately $59,000. Covestor Ltd lifted its stake in Acadia Healthcare by 834.4% during the third quarter. Covestor Ltd now owns 1,140 shares of the company’s stock worth $72,000 after purchasing an additional 1,018 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale bought a new position in shares of Acadia Healthcare in the 3rd quarter worth about $86,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.